(Q36366487)

13 August 2017

1 reference

title

Renal fibrosis: new insights into the pathogenesis and therapeutics (English)

1 reference

13 August 2017

0 references

1 reference

Youhua Liu

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

213-217

1 reference

Chronic renal diseases as a public health problem: epidemiology, social, and economic implications

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Molecular basis of renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Mechanisms of tubulointerstitial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Wound healing in the kidney: complex interactions in renal interstitial fibrogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Epithelial-mesenchymal transition and its implications for fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

TGF-beta signaling in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

TGF-beta signal transduction and mesangial cell fibrogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Plasmin is not protective in experimental renal interstitial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000054

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000054

1 reference

Dimensions Publication ID

13 August 2017

1027548117

0 references

1 reference